(CS) AXA - PA
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: PA (France) | Market Cap: 86.455m EUR | Total Return: 9.4% in 12m
Avg Turnover: 148M
Warnings
Choppy
Tailwinds
No distinct edge detected
AXA SA is a Paris-based global provider of insurance, asset management, and banking services. Operating across diverse geographical segments including Europe, Asia, and Africa, the company maintains a comprehensive portfolio encompassing life, savings, property, and casualty insurance. Its business model relies heavily on risk diversification through its AXA XL division, which provides specialized reinsurance and commercial coverage for complex liabilities such as environmental, marine, and aviation risks.
The company integrates technology into its service delivery through digital ecosystems, including the AXA Multilink platform and generative AI assistants for customer interaction. As a multi-line insurer, AXA benefits from a balanced revenue stream derived from both retail premiums and institutional asset management fees, a structure common among large-scale European financial conglomerates. For a deeper look into the companys financial health, investors can review detailed valuation metrics on ValueRay.
Founded in 1852, AXA has evolved into a global systemic insurer with a significant presence in both mature and emerging markets. Its operations extend beyond traditional indemnity to include healthcare solutions, teleconsultation services, and integrated risk management consulting for corporate clients.
- AXA XL commercial lines pricing power drives underwriting margin expansion
- High interest rates bolster investment income and life insurance profitability
- European regulatory changes and Solvency II ratios impact capital return capacity
- Expansion of health and protection services increases fee-based revenue streams
- Natural catastrophe frequency and severity volatility affects property and casualty earnings
| Net Income: 9.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.55 > 1.0 |
| NWC/Revenue: -538.8% < 20% (prev 402.6%; Δ -941.3% < -1%) |
| CFO/TA 0.03 > 3% & CFO 21.5b > Net Income 9.80b |
| Net Debt (39.6b) to EBITDA (10.1b): 3.91 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.03b) vs 12m ago -8.98% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 12.49% > 50% (prev 12.51%; Δ -0.02% > 0%) |
| Interest Coverage Ratio: 17.33 > 6 (EBIT TTM 10.9b / Interest Expense TTM 627.0m) |
| A: -0.68 (Total Current Assets 46.1b - Total Current Liabilities 480b) / Total Assets 636b |
| B: 0.07 (Retained Earnings 41.4b / Total Assets 636b) |
| C: 0.02 (EBIT TTM 10.9b / Avg Total Assets 645b) |
| D: 0.07 (Book Value of Equity 42.6b / Total Liabilities 586b) |
| Altman-Z'' = -4.08 = D |
| DSRI: 2.45 (Receivables 23.9b/9.90b, Revenue 80.5b/81.8b) |
| GMI: 0.75 (GM 102.3% / 135.6%) |
| AQI: 1.96 (AQ_t 0.92 / AQ_t-1 0.47) |
| SGI: 0.98 (Revenue 80.5b / 81.8b) |
| TATA: -0.02 (NI 9.80b - CFO 21.5b) / TA 636b) |
| Beneish M = -1.50 (Cap -4..+1) = D |
As of June 26, 2026, the stock is trading at EUR 43.09 with a total of 2,588,076 shares traded. Over the past week, the price has changed by +1.63%, over one month by +6.47%, over three months by +19.87% and over the past year by +9.37%.
Current recommended Stop Loss: 42.20 (which is 2.1% or 1.5 ATR below the current price).
AXA has no consensus analysts rating.
P/E Trailing = 12.4269
P/E Forward = 10.2881
P/S = 0.913
P/B = 1.8328
P/EG = 1.2122
Revenue TTM = 80.5b EUR
EBIT TTM = 10.9b EUR
EBITDA TTM = 10.1b EUR
Long Term Debt = 60.5b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.78b EUR (from shortTermDebt, last fiscal year)
Debt = 61.9b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 39.6b EUR (calculated: Debt 61.9b - CCE 22.2b)
Enterprise Value = 126b EUR (86.5b + Debt 61.9b - CCE 22.2b)
Interest Coverage Ratio = 17.33 (Ebit TTM 10.9b / Interest Expense TTM 627.0m)
EV/FCF = 5.99x (Enterprise Value 126b / FCF TTM 21.1b)
FCF Yield = 16.70% (FCF TTM 21.1b / Enterprise Value 126b)
FCF Margin = 26.14% (FCF TTM 21.1b / Revenue TTM 80.5b)
Net Margin = 12.16% (Net Income TTM 9.80b / Revenue TTM 80.5b)
Gross Margin = unknown ((Revenue TTM 80.5b - Cost of Revenue TTM -28.7b) / Revenue TTM)
Tobins Q-Ratio = 0.20 (Enterprise Value 126b / Total Assets 636b)
Interest Expense / Debt = 1.01% (Interest Expense 627.0m / Debt 61.9b)
Taxrate = 23.67% (2.37b / 10.00b)
NOPAT = 8.29b (EBIT 10.9b * (1 - 23.67%))
Current Ratio = 0.10 (Total Current Assets 46.1b / Total Current Liabilities 480b)
Debt / Equity = 1.45 (Debt 61.9b / totalStockholderEquity, last quarter 42.6b)
Debt / EBITDA = 3.91 (Net Debt 39.6b / EBITDA 10.1b)
Debt / FCF = 1.88 (Net Debt 39.6b / FCF TTM 21.1b)
Total Stockholder Equity = 44.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.52% (Net Income 9.80b / Total Assets 636b)
RoE = 21.83% (Net Income TTM 9.80b / Total Stockholder Equity 44.9b)
RoCE = 10.31% (EBIT 10.9b / Capital Employed (Equity 44.9b + L.T.Debt 60.5b))
RoIC = 5.47% (NOPAT 8.29b / Invested Capital 151b)
WACC = 3.86% (E(86.5b)/V(148b) * Re(6.07%) + D(61.9b)/V(148b) * Rd(1.01%) * (1-Tc(0.24)))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -6.97%
[DCF] Terminal Value 77.97% ; FCFF base≈17.3b ; Y1≈19.8b ; Y5≈29.1b
[DCF] Fair Price = 195.8 (EV 438b - Net Debt 39.6b = Equity 398b / Shares 2.03b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.81 | EPS CAGR: 18.42% | SUE: 0.0 | # QB: 0
Revenue Correlation: -44.21 | Revenue CAGR: -8.45% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=4.12 | Chg30d=+0.00% | Revisions=-27% | GrowthEPS=+6.7% | GrowthRev=+25.4%
EPS next Year (2027-12-31): EPS=4.45 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+8.1% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -27%